Artisan Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.8M Buy
+368,074
New +$69.2M 0.11% 153
2024
Q4
Sell
-22,606
Closed -$3.52M 369
2024
Q3
$3.52M Sell
22,606
-2,264
-9% -$365K 0.01% 319
2024
Q2
$3.88M Sell
24,870
-84,172
-77% -$12.7M 0.01% 316
2024
Q1
$14.8M Sell
109,042
-298,733
-73% -$39.6M 0.02% 290
2023
Q4
$54.9M Sell
407,775
-857,627
-68% -$111M 0.08% 209
2023
Q3
$171M Buy
1,265,402
+177,571
+16% +$24.3M 0.29% 87
2023
Q2
$156M Sell
1,087,831
-60,174
-5% -$8.85M 0.25% 96
2023
Q1
$159M Buy
1,148,005
+34,476
+3% +$4.64M 0.26% 92
2022
Q4
$151M Buy
+1,113,529
New +$140M 0.27% 90

Other funds holding AZN

Artisan Partners's AZN Position: Q2 2026 in Review

Artisan Partners opened a new position in AstraZeneca (AZN) in Q2 2026: 368,074 shares worth $69.8M. The stake represents 0.11% of the portfolio and ranks #153 among its holdings. This is a return to the name: Artisan Partners previously reported a position in AZN as recently as Q3 2024.

Artisan Partners first reported a position in AZN in Q4 2022 and has held it in 9 quarters since. The position peaked at $171M in Q3 2023. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Artisan Partners held 368,074 shares of AstraZeneca worth $69.8M as of Q2 2026.
  • AstraZeneca was a new Artisan Partners position in Q2 2026.
  • AstraZeneca made up 0.11% of Artisan Partners's portfolio in Q2 2026, its #153 holding.
  • Artisan Partners first reported a position in AstraZeneca in Q4 2022 and has held it in 9 quarters since.
  • Artisan Partners's AstraZeneca position peaked at $171M in Q3 2023.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.